Private Equity Portfolio COOs face increasing pressure to unlock value from GenAI, yet the reality is sobering: only 5% of portfolio companies successfully scale these initiatives beyond the pilot stage, unable to demonstrate short-term value, and not able to turn GenAI strategy into execution.
To operationalize GenAI at scale, COOs must embrace a pragmatic, results-driven approach that integrates GenAI into the fabric of core operations. These cannot be one-off initiatives, justified by ambitious run-rate ROI promises. Change at scale requires a relentless focus aimed at improving the “ways of working”.
With over $1.5 billion in EBITDA improvements across 60+ PE engagements, SSA & Co. has a proven track record of turning technology ambition into measurable business outcomes. Our GenAI playbook is designed to move with pace and deliver within holding periods.
External headwinds and difficult performance outlooks have forced private equity firms to rethink near-term prospects and portfolio company strategies. In this Value Walk article, Matt Katz and Andrew Solar outline a new playbook for private equity companies leading in uncertainty.
Learn More
As 2025 unfolds, private equity firms are approaching the market with caution. The wounds of 2024—a year weighed
Learn More
Better resource management can help insurers avoid wasting time and resources on projects. Brian Nordyke and Jonathan Schwartz offer insights to enhance operational efficiency in this Insurance Thought Leadership article.
Learn More